News
NIH inventors are seeking a licensee and/or collaborator for a gene therapy to increase melanin production in patients with oculocutaneous albinism (OCA). OCA is characterized by decreased or absent pigmentation in the hair, skin, and eyes. This lack of pigmentation, caused by insufficient melanin
Dr. Barney S. Graham and Dr. Kizzmekia Corbett have been awarded the Federal Employee of the Year Award for “conducting groundbreaking research that led to the development of highly effective vaccines in record time that are protecting hundreds of millions of people from contracting the deadly
Join the National Institute of Child Health and Human Development (NICHD)’s Dr. Tracey Rouault for a free webinar on a compound, TEMPOL, that could potentially be formulated into a preventative and oral treatment for COVID-19. When SARS-CoV-2 enters a host, the cells replicate it and viral particles
Inventors at the National Cancer Institute’s Laboratory of Molecular Biology have isolated three anti Programed Death-Ligand 1 (PD-L1) single domain antibodies that can be used as a therapeutic for treating solid tumors. An imbalance of PD-L1 contributes to cancer immune escape and it has been